Reengineered monoclonal antibodies step up to the plate in cancer studies.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D007938:Leukemia / Q000628:therapy; D008223:Lymphoma / Q000276:immunology / Q000628:therapy; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*
D000911:Antibodies, Monoclonal